[Congressional Record Volume 167, Number 88 (Thursday, May 20, 2021)]
[Senate]
[Page S3233]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1772. Mr. LANKFORD (for himself and Mr. Tillis) submitted an 
amendment intended to be proposed to amendment SA 1502 proposed by Mr. 
Schumer to the bill S. 1260, to establish a new Directorate for 
Technology and Innovation in the National Science Foundation, to 
establish a regional technology hub program, to require a strategy and 
report on economic security, science, research, innovation, 
manufacturing, and job creation, to establish a critical supply chain 
resiliency program, and for other purposes; which was ordered to lie on 
the table; as follows:

     At the appropriate place, insert the following:

     SEC. ___. CONGRESSIONAL REVIEW PROCEDURES FOR WAIVER OF 
                   OBLIGATIONS WITH RESPECT TO VACCINES OR OTHER 
                   BIOTECHNOLOGY COMMODITIES UNDER THE AGREEMENT 
                   ON TRADE-RELATED ASPECTS OF INTELLECTUAL 
                   PROPERTY RIGHTS.

       Section 122 of the Uruguay Round Agreements Act (19 U.S.C. 
     3532) is amended by adding at the end the following:
       ``(e) Approval by Congress of Certain Waivers With Respect 
     to Vaccines or Other Biotechnology Commodities.--
       ``(1) In general.--A waiver described in paragraph (2) 
     granted under subsection (b)(2) shall not enter into force 
     with respect to the United States, and no funds shall be used 
     by the Secretary of Commerce, the Secretary of Health and 
     Human Services, or the Trade Representative to implement the 
     terms of that waiver, unless--
       ``(A) the President submits the text of the proposed waiver 
     agreement to the appropriate congressional committees; and
       ``(B) a joint resolution is enacted approving the waiver 
     not later than 180 days after the later of the date on 
     which--
       ``(i) the report under subsection (c)(2)(A) with respect to 
     that waiver is submitted; or
       ``(ii) the text of the proposed waiver agreement under 
     subparagraph (A) is submitted.
       ``(2) Waiver described.--A waiver described in this 
     paragraph is a waiver of certain provisions of the Agreement 
     on Trade-Related Aspects of Intellectual Property Rights 
     referred to in section 101(d)(15) for a vaccine or other 
     biotechnology commodity.
       ``(3) Introduction and referral of joint resolution.--A 
     joint resolution under paragraph (1)(B) may be introduced by 
     any member of Congress and shall be referred--
       ``(A) in the Senate, to the Committee on Finance; and
       ``(B) in the House of Representatives, to the Committee on 
     Ways and Means.''.
                                 ______